Pharmaceuticals
Cipla to slash prices of six more cancer drugs
11 May 2012
Drugmaker Cipla will slash prices of six more cancer drugs on humanitarian grounds, a decade after it shook multination giants by slashing prices of AIDS and later malaria drugs
Abbott to pay $1.6 bn to settle Depakote epilepsy drug suits
09 May 2012
Pleading guilty, Abbott will pay federal and state governments $800 million in civil fines, $700 million in criminal penalties and $100 million to states to resolve consumer offences
Cipla slashes prices of three key cancer drugs
03 May 2012
Cipla Ltd today announced that it had slashed the prices of its key drugs for the treatment of three types of cancers that affect kidney, lungs and brain
China sales, Singulair drive Merck’s Q1-2012 net to $3 bn
28 Apr 2012
Merck's worldwide sales for the first quarter of 2012 rose just one per cent to $11.7 billion due to the unfavorable impact from the arbitration settlement agreement with Johnson & Johnson
Watson Pharmaceuticals to buy Swiss rival Actavis for $5.60 billion
26 Apr 2012
The proposed acquisition will catapult Watson, the fifth-largest US pharma company, into the world’s third-biggest generic drugmaker with expected 2012 revenue of $8 billion.
Baxter to set up $1-bn plant for plasma-based therapies
21 Apr 2012
The capital investment for the plant is expected to exceed $1 billion over the next five years and create more than 2000 jobs across the US
Aspen to buy GSK’s international OTC brands
20 Apr 2012
Roche ends $6.7-bn hostile bid for Illumina
19 Apr 2012
The potential acquisition of Illumina would have made Roche a market leader in gene sequencing, a procedure that helps develop targeted therapies
Piramal Healthcare buys Bayer’s molecular imaging and research portfolio
16 Apr 2012
The acquisition includes Florbetaben, a drug candidate for diagnosis of Alzheimer’s disease that is in the final stages of clinical trials, with potential to generate annual revenues of $1.5 billion
Featured articles
Lighter than air, yet very, very powerful
By Kiron Kasbekar | 03 Jan 2024
In March 2013 Chinese scientists pulled off a remarkable feat. They created the world’s lightest aerogel. Tipping the scales at a mere 0.16 milligrams per cubic centimeter – that’s a sixth of the weight of air!
COP28 explained: A closer look at COP28's climate change solutions
By Aniket Gupta | 27 Dec 2023
The 28th United Nations Climate Change Conference, also known as COP28, took place from 30th November 2023, to 13th December 2023, at Expo City in Dubai, United Arab Emirates.
What is a Ponzi scheme?
By Aniket Gupta | 06 Dec 2023
Ponzi schemes have long captivated the public imagination, drawing unsuspecting investors into a web of illusion and deception.
The Rise and Rise of HDFC Bank
03 Jul 2023
HDFC, which surged ahead of global majors like HSBC Holdings Plc and Citigroup Inc and left Indian peers like State Bank of India and ICICI Bank in market capitalisation, now ranks fourth largest among the world’s most valuable banks, after JPMorgan Chase & Co, Industrial and Commercial Bank of China Ltd and Bank of America Corp
India’s Millet Revolution To Enrich Global Food Basket
02 Apr 2023
Millets, a healthier and cheaper substitute to wheat and rice, are indigenous to many parts of the world, especially in the semiarid tropics of Asia and Africa, and offers a big scope for expanding production and consumption in the foodgrain deficient African continent
Market predator Hindenburg preys on Adani stock
06 Mar 2023
Almost a month after the damning report of short-seller Hindenburg Research on the Adani Group that claimed that the seven stocks within the group were about 85 per cent overvalued, one of the group's stocks, Adani Total Gas, closed at Rs835 on the BSE, down nearly 79 per cent from its 24 January level, almost close to reaching that valuation
.jpg "CBDT explains Budget proposal on capital gains tax")
.jpg "Economic Survey projects India’s GDP growth at 6.5–7% in 2024-25")
.jpg "Adani-Sirus joint venture to acquire 77.5% stake in Coredge.io parent Parserlabs")
